BRANFORD, Conn. — Isoplexis, the leader in functional single cell proteomics, announced today that it has been awarded a Phase 2 Small Business Innovation Research (SBIR) grant from the National Institute on Aging of the National Institutes of Health for $2 million to continue analyzing the highly multiplexed proteomic responses of trafficking leukocytes in patients with Alzheimer’s disease, neuroinflammation, […]

Cambridge, UK — Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications – today announced the successful closure of a £1.5M series A investment round to accelerate the global scale-up of its commercial operations and make key hires to its leadership team. The funding round attracted support from a […]

BALTIMORE, MD  – PathSensors Inc., a Baltimore biotechnology company, announced today the completion of Phase I of a Small Business Innovation Research (SBIR) program funded by the National Institute of Food and Agriculture (NIFA) entitled “Food Safety in the 21st Century: Rapid Toxin Detection in the Field”. The project’s goal was to engineer and develop a […]

Funding will support product range extension of micro-chip based µPAC™ nano, capillary and microflow LC columns, and accelerated development of manufacturing process know-how. PharmaFluidics NV, innovative player in the field of analytical chromatography with its unique high-resolution µPAC™ micro-Chip technology, announces that it has been awarded a € 613 k grant from Flanders’ Innovation & […]

LabMinds adding value to customers’ COVID-19 drug discovery and development BOSTON — LabMinds, Inc., an award-winning robotics company in life sciences, today announced it has closed a fully subscribed funding round from a mix of private and strategic investors.  The round was closed at a 20% higher share price than the funding round completed in 2019, reflecting the […]

SAN FRANCISCO — Benchling, the leading life sciences R&D cloud platform, announced it closed $50 million in Series D funding led by Alkeon and joined by new investors Spark Capital, Lux Capital and ICONIQ Partners, as well as existing investors Thrive Capital and Benchmark. The round comes at one of the most pivotal moments for the biotechnology industry […]

Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital.  The funding comes from new investors and existing shareholders in EMEA, US and Asia, and adds to the £29M of new capital raised in Q4 2019. Further information on Oxford Nanopore’s fundraising will be made available after full closing. Oxford Nanopore’s sequencing devices are used […]

Vulcan Capital-led investment will enable Nautilus to bring a next-generation, single-molecule proteomics platform to market. San Carlos, CA and Seattle, WA, May 21, 2020 — Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that […]

SAN DIEGO– Illumina, Inc. (NASDAQ: ILMN) is committed to supporting the global, national and local relief efforts of our customers, employees and communities, as we unite to combat COVID-19. Giving back is in our DNA, and together with the Illumina Corporate Foundation, we have committed more than $10M to support the communities where we live […]

Mérieux Equity Partners and Korys announce the launch of a new investment platform in Venture Capital to support innovative companies in the healthcare and nutrition sectors, in Europe and North America. OMX Europe Venture Fund FPCI (“OMX Europe”) was launched with a significant financial commitment representing more than two thirds of the target size of […]